N

Navamedic ASA
OSE:NAVA

Watchlist Manager
Navamedic ASA
OSE:NAVA
Watchlist
Price: 25.2 NOK -0.79% Market Closed
Market Cap: 604.3m NOK

Wall Street
Price Targets

NAVA Price Targets Summary
Navamedic ASA

Wall Street analysts forecast NAVA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NAVA is 36.72 NOK with a low forecast of 36.36 NOK and a high forecast of 37.8 NOK.

Lowest
Price Target
36.36 NOK
44% Upside
Average
Price Target
36.72 NOK
46% Upside
Highest
Price Target
37.8 NOK
50% Upside
Navamedic ASA Competitors:
Price Targets
ETON
Eton Pharmaceuticals Inc
83% Upside
PFIZER
Pfizer Ltd
25% Upside
SLGL
Sol Gel Technologies Ltd
31% Upside
LUPIN
Lupin Ltd
9% Upside
600196
Shanghai Fosun Pharmaceutical Group Co Ltd
34% Upside

Revenue
Forecast

Revenue Estimate
Navamedic ASA

For the last 13 years the compound annual growth rate for Navamedic ASA's revenue is 17%. The projected CAGR for the next 3 years is 17%.

17%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Navamedic ASA

The compound annual growth rate of Navamedic ASA's operating income for the next 3 years is 30%.

N/A
Past Growth
30%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Navamedic ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NAVA's stock price target?
Price Target
36.72 NOK

According to Wall Street analysts, the average 1-year price target for NAVA is 36.72 NOK with a low forecast of 36.36 NOK and a high forecast of 37.8 NOK.

What is Navamedic ASA's Revenue forecast?
Projected CAGR
17%

For the last 13 years the compound annual growth rate for Navamedic ASA's revenue is 17%. The projected CAGR for the next 3 years is 17%.

What is Navamedic ASA's Operating Income forecast?
Projected CAGR
30%

The compound annual growth rate of Navamedic ASA's operating income for the next 3 years is 30%.

Back to Top